EUVIMEDEUVIMED entdecken
Fallbericht

Cutaneous rhabdomyosarcoma with FUS::TFCP2 fusion: A case report emphasizing early detection

Cuyan Demirkesen iD, Ayça Erşen Danyeli iD, Pelin Yıldız iD, Sümeyre Seda Ertekin iD, Berkhan Yılmaz iD, Süleyman İzzet Karahan iD, Armita Bahrami iD

Journal of Cutaneous Pathology · 2023

DOI: 10.1111/cup.14526 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Cutaneous Pathology, 2023. Verfasst von Cuyan Demirkesen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Acıbadem University, School of Medicine, Istanbul, Turkey. Hauptthemen laut MEDLINE: Rhabdomyosarcoma, Bone Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rhabdomyosarcoma with TFCP2 rearrangement is a recently identified malignant neoplasm characterized by immunohistochemical evidence of rhabdomyoblastic differentiation, keratin expression, upregulation of ALK, and an aggressive clinical course. This neoplasm has a tendency to affect craniofacial bones, with only a few reported cases of extra‐osseous tumors. Here, we present a case of cutaneous rhabdomyosarcoma with FUS::TFCP2 fusion in a 35‐year‐old female. Notably, the tumor exhibited a pathologic spectrum, initially resembling sclerosing dermatitis at presentation but progressing into a high‐grade malignant tumor within 8 months. The distinctive immunoprofile of this neoplasm highlights the importance of early molecular studies for diagnosis, even in the presence of low‐grade cytomorphology. Early detection may offer an opportunity for timely resection before the tumor becomes unresectable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RhabdomyosarcomaBone NeoplasmsFemaleHumansAdultEarly Detection of CancerTranscription FactorsBiomarkers, TumorDNA-Binding ProteinsRNA-Binding Protein FUS

Stichwörter der Autor:innen

FUS-TFCP2TCFP2cutaneous rhabdomyosarcomaepithelioid and spindle cell rhabdomyosarcoma

Substanzen

Transcription FactorsBiomarkers, TumorTFCP2 protein, humanDNA-Binding ProteinsFUS protein, humanRNA-Binding Protein FUS

Autor:innen und Institutionen

  • Department of Pathology, Acıbadem University, School of Medicine, Istanbul, Turkey.
  • Department of Dermatology, Koç University School of Medicine, Istanbul, Turkey.
  • Department of Plastic, Reconstructive & Aesthetic Surgery, Acıbadem Universiy School of Medicine, Istanbul, Turkey.
  • Department of Dermatology, Acıbadem Hospital, Istanbul, Turkey.
  • Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.

ORCID-Profile: Cuyan Demirkesen, Ayça Erşen Danyeli, Pelin Yıldız, Sümeyre Seda Ertekin, Berkhan Yılmaz, Süleyman İzzet Karahan, Armita Bahrami

Zitieren

APA

Demirkesen, C., Danyeli, A. E., Yıldız, P., Ertekin, S. S., Yılmaz, B., Karahan, S. İ., & Bahrami, A. (2023). Cutaneous rhabdomyosarcoma with FUS::TFCP2 fusion: A case report emphasizing early detection. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14526

Vancouver

Demirkesen C, Danyeli AE, Yıldız P, Ertekin SS, Yılmaz B, Karahan Sİ, et al. Cutaneous rhabdomyosarcoma with FUS::TFCP2 fusion: A case report emphasizing early detection. Journal of Cutaneous Pathology. 2023. doi:10.1111/cup.14526

BibTeX
@article{Demirkesen2023,
  author = {Demirkesen, Cuyan and Danyeli, Ayça Erşen and Yıldız, Pelin and Ertekin, Sümeyre Seda and Yılmaz, Berkhan and Karahan, Süleyman İzzet and Bahrami, Armita},
  title = {Cutaneous rhabdomyosarcoma with FUS::TFCP2 fusion: A case report emphasizing early detection},
  journal = {Journal of Cutaneous Pathology},
  year = {2023},
  doi = {10.1111/cup.14526}
}
Kostenlos starten →